Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure
NCT04374734 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-10-07
Summary
Acute respiratory failure (ARF) is a common condition and a common reason for urgent medical consultation. Assessing the extent of respiratory impairment is important to improve the management of patients with ARF. When Acute respiratory failure is caused by pathology of the pulmonary parenchyma, quantification of pulmonary radiographic involvement may be a component of the initial assessment of severity. This radiographic quantification would only be usable in clinical routine if it can be automated and provide a real-time result.
The objective of this work is to assess the feasibility of an automated technique for quantifying radiological lung damage in situations of known or potential ARF.
Conditions
- SARS (Severe Acute Respiratory Syndrome)
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-05
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-30
Countries
- France
Study Locations
More Related Trials
-
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
NCT06853145 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Functional Respiratory Imaging in Bronchiectasis
NCT03818646 ·Status: UNKNOWN
-
An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors
NCT05784207 ·Status: COMPLETED
-
A Single-Centre Pilot Study Exploring the Utility of Magnetic Resonance Imaging in Patients With Chronic Lung Disease
NCT02723474 ·Status: COMPLETED ·Phase: NA
-
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
NCT04872309 ·Status: SUSPENDED
-
Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases
NCT06537934 ·Status: RECRUITING
-
Digital Modeling of Thoracic CT and Pulmonary Fibrosis
NCT06618924 ·Status: ACTIVE_NOT_RECRUITING
-
Research to Evaluate a Possible Relation Between Values Obtained After Processing CT Images, Lung Function Tests and the Experience of the Patient During an Exacerbation in COPD Patients.
NCT01684384 ·Status: COMPLETED ·Phase: NA
-
Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases
NCT02961335 ·Status: TERMINATED ·Phase: NA
-
Ultra-Low Dose Computed Tomography For Diagnosis And Follow-Up Of Patients With Diffuse Parenchymal Lung Disease (DPLD)
NCT04392726 ·Status: UNKNOWN
-
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
NCT04362644 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis
NCT01247142 ·Status: COMPLETED
-
A Long-term Follow-up Study of Pulmonary Function Changes Using Phase-resolved Functional Lung MRI in Patients With COVID-19
NCT05933317 ·Status: UNKNOWN
-
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
NCT02748798 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection
NCT04584671 ·Status: ACTIVE_NOT_RECRUITING
-
Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot Study
NCT03979430 ·Status: COMPLETED ·Phase: NA
-
Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/
NCT04072315 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
NCT06323876 ·Status: RECRUITING
-
Hyperpolarized 129Xe MRI Lung Health Cohort
NCT05766384 ·Status: RECRUITING
-
Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images
NCT04483752 ·Status: UNKNOWN ·Phase: NA
-
Ultrasound of the Diaphragm Excursion Ratio as Physiological Biomarker in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
NCT07259174 ·Status: RECRUITING
-
Prospective Cohort of Patients With Fibrosing Interstitial Lung Disease Admitted for Acute Respiratory Failure
NCT06855004 ·Status: RECRUITING
-
Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae
NCT04519320 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Deep Learning Diagnostic and Risk-stratification for IPF and COPD
NCT05318599 ·Status: RECRUITING
-
Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases
NCT01600378 ·Status: RECRUITING